Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102

Title
Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102
Authors
Keywords
AML, Prodrug, Leukemia, Triptolide, MRx102, Toxicology, Toxicokinetics
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 73, Issue 5, Pages 961-974
Publisher
Springer Nature
Online
2014-03-12
DOI
10.1007/s00280-014-2428-6

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started